Table 1.
Chromosome cytoband start location | Types of alteration in tumor | ||||
---|---|---|---|---|---|
Tumor 1 | Tumor 2 | Tumor 3 | Tumor 4 | Tumor 5 | |
1q31.1 | – | LOH | – | Gain | Gain |
3p26.3 (26, 27) | – | – | Loss | Loss | Loss |
4q31.2 | – | – | Loss | Gain | Gain |
4q35.1 (FAT1) (1, 31) | – | – | Loss | Loss | Gain |
5q11.2 | Loss | – | – | Loss | Loss |
6p25.2 | LOH | – | Gain | Gain | LOH |
7p11.2 (EGFR) (1, 31) | – | – | Gain | Gain | Gain |
9p23 | LOH | Gain | Gain | Loss | LOH |
11q13.3 (CCND1, FADD, CTTN) (1) | Gain | – | Gain | – | Gain |
12q24.12 (ALDH2) | LOH | LOH | – | Gain | – |
13q13.1 | Loss | – | – | LOH | Loss |
15q11.2 | Gain | – | Loss | Loss | Gain |
16p13.3 | LOH | – | Loss | Gain | Gain |
17p13.2 (TP53) (1, 31) | LOH | – | – | LOH | Gain + LOH |
20q11.21 | Gain | – | Gain | – | Gain |
22q11.23 (GSTT1) | – | – | Gain | Gain | Gain |
The same chromosomal location revealed intertumoral genetic diversity of all five tumors based on either (a) a discrepancy in the genetic alterations (gain, loss, or LOH) or (b) the presence/absence of a genetic alteration only in certain tumors.